Ad is loading...
MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

MREO Mereo BioPharma Group plc Forecast, Technical & Fundamental Analysis

a company, which engages in therapeutics that aim to improve outcomes for patients with osteogenesis imperfecta, alpha-1 antitrypsin deficiency, hypogonadotropic hypogonadism in obese men, and acute exacerbations of chronic obstructive pulmonary disease

Industry Biotechnology
MREO
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For MREO
(Try 14 days for Free)
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
MREO
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For MREO
(Try 14 days for Free)
Ad is loading...
A.I. Advisor
published Earnings

MREO is expected to report earnings to fall 130.00% to 0 cents per share on March 26

Mereo BioPharma Group plc MREO Stock Earnings Reports
Q4'24
Est.
$0.01
Q3'24
Est.
$-0.02
Q2'24
Missed
by $0.01
Q4'23
Est.
$-0.02
Q2'23
Est.
$-0.02
The last earnings report on November 12 showed earnings per share of -1 cents, meeting the estimate of -1 cents. With 2.14M shares outstanding, the current market capitalization sits at 547.66M.
A.I. Advisor
published General Information

General Information

a company, which engages in therapeutics that aim to improve outcomes for patients with osteogenesis imperfecta, alpha-1 antitrypsin deficiency, hypogonadotropic hypogonadism in obese men, and acute exacerbations of chronic obstructive pulmonary disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Cavendish Place
Phone
+44 3330237300
Employees
33
Web
https://www.mereobiopharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MTRIX20.76-0.05
-0.24%
MFS Total Return I
ADNCX13.71-0.09
-0.65%
American Beacon ARK Transfmt Innov C
JRSCX11.47-0.13
-1.12%
JH Adaptive Risk Mgd U.S. Eq C
GDEUX22.79-0.28
-1.21%
Goldman Sachs U.S. Equity ESG R6
GSWPX25.22-0.49
-1.91%
Goldman Sachs Small/Mid Cap Growth P

MREO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been loosely correlated with MDGL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MREO jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
-7.59%
MDGL - MREO
37%
Loosely correlated
-4.66%
INZY - MREO
32%
Poorly correlated
-8.89%
TERN - MREO
32%
Poorly correlated
-5.80%
XERS - MREO
31%
Poorly correlated
-4.26%
ARRY - MREO
30%
Poorly correlated
-10.22%
More